Number of pages: 100 | Report Format: PDF | Published date: 13 February, 2023
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
Report Attribute |
Details |
Market size value in 2021 |
US$ 164 million |
Revenue forecast in 2030 |
US$ 281 million |
Growth Rate |
CAGR of 6.2% from 2022 to 2030 |
Base year for estimation |
2021 |
Forecast period |
2022-2030 |
Historical Year |
2020 |
Segments covered |
Product Type, Technology, End User, and Region |
Regional scope |
North America, Europe, Asia Pacific, and the Rest of the World (ROW) |
According to the deep-dive market assessment study by Growth+ Reports, the global microtome equipment market is valued at US$ 164 million in 2021, expected to witness a CAGR of 6.2% during the forecast period from 2022 to 2030.
Market Fundamentals
A microtome is equipment that slices a block of implanted tissue into extremely thin slices regularly and precisely. Microtome equipment is used to prepare samples for electron or diffused light microscopy examination. Frozen tissues are sectioned using specialist microtomes and paraffin- and plastic-embedded tissues using several types of microtomes. Microtomes may use steel, glass, or diamond blades depending on the specimen being cut into and the desired thickness of the sections being cut. Light microscopy histological slices of animal or plant tissues are prepared using steel blades. For both cutting very thin sections for electron microscopy and cutting sections for light microscopy, glass knives are utilized. There are various varieties of microtomes, each built for a particular function, though many serve multiple purposes. In honor of its designer, the rotary microtome is frequently called the "Minot." The rotary microtome can be fully automated, semi-automated (one motor advances either the fine or course hand-wheel), or manual (totally controlled by the user) (two motors that drive both the fine and the course advance hand-wheel). A vibrating blade is used in vibrating microtomes, which makes it easier to cut samples. This microtome is frequently used for processing biological materials such as nerve tissues, the brain, and the spinal cord and applies less pressure than would be necessary with a stationary blade. To guarantee the retention of high-quality viable cells, the instrument's stability lowers the mechanical forces acting on the tissue sample.
Microtomy automation has benefited from technological advancements that have enhanced productivity, improved worker safety, and improved section quality. Repetitive motion disorders, a prevalent occupational health issue in the histology lab, are less likely to occur when the microtome is not operated manually.
[465464]
Market Dynamics
The rising incidence of chronic diseases, the growing elderly population, and the increasing cost of healthcare, particularly in developed nations, are the primary factors driving the global market for microtome equipment. One of the main drivers projected to spur growth is the expanding commercial availability of high-quality diagnostic technology in developed economies, accounting for most of the revenue share. However, there is an unmet demand for technologically improved diagnostic equipment because of lower per capita disposable income and less commercial availability in developing countries. Additionally, producers of diagnostic equipment frequently choose to locate their factories in developing nations like Brazil, India, and China, as well as those with sizable domestic markets. Additionally, the global microtome equipment market has expanded because of the increased prevalence of chronic diseases, including cancer and diabetes. To determine whether tumor cells are present, examining tissues is necessary for oncology diseases. As a result, the global microtome equipment market will expand due to the increased cancer incidence. For example, the World Health Organization (WHO) estimates that more than 3.7 million new cases and 1.9 million deaths occur annually in Europe, with cancer ranking as the continent's second-leading cause of mortality and morbidity. However, due to the lack of skilled professionals, the microtome equipment market is expected to face challenges in terms of growth.
The global microtome equipment market has been analyzed from four perspectives: Product Type, Technology, End User, and Region.
Microtome Equipment Market by Product Type
[6454353]
Based on product type, the global microtome equipment market is subdivided into microtome devices and accessories. The microtome devices are further divided into vibrating microtomes, rotary microtomes, and others. Microtome devices emerged as the dominating type of product segment. The revenue share can be attributed in part to the commercial availability of these systems and their widespread adoption due to their ease of use. The Semi-Automatic Rotary Microtome M530 from MEDITE GmbH and the Cryostat Microtome SMI-3010 from S.M. Scientific Instruments Pvt. Ltd., CUT 4062 manual precision microtome, and the Boeckeler Instruments, Inc. CR-X Cryo system dominate the market. Due to its significant commercial presence compared to other types of devices, the rotary microtome segment of the device market accounts for the majority of revenue. One important factor in expanding the market is that more than 60% of commercial devices are rotary. Due to the growing demand for these accessories in hospitals and clinics, and technological advancements, such as portability and user-friendly operability, the accessories segment is anticipated to experience the most growth.
Microtome Equipment Market by Technology
Based on technology, the global microtome equipment market has been divided into manual, fully automated, and semi-automated. The fully automated microtomes segment holds the majority of the global microtome equipment market share owing to the growing demand for technologically advanced products, especially in developed economies such as the U.S., Germany, France, and Japan. Additionally, it is anticipated that this segment will expand the fastest during the projected period. Large-scale fully automated commercially available systems and the rising need for digitalization of tissue diagnostic processes are some of the key factors projected to boost the market. Some key automated products are Tissue Surgeon, Tissue-Tek Auto Section Automated Microtome, and PT-PC Power Tomes. The semi-automated microtomes make up the second largest share, because they are ideal for routine sectioning and research applications in pathology and histopathology. In contrast, manual microtomes, which necessitate manual adjustments, have the lowest market share. However, manual microtomes are preferred in developing economies due to their low costs.
Microtome Equipment Market by End User
Based on end user, the global microtome equipment market has been divided into, hospitals, pharmaceutical & biotechnology companies, ambulatory surgical centers, and pathology laboratories. Hospital Laboratories dominate the global market for microtomes. The high volume of routine tissue examinations carried out in hospital-based laboratories worldwide, and the expanding patient population are two of the primary contributors to the growth of hospitals segment in the global microtome equipment market. Due to the rising number of diagnostic labs and the expanding number of patients, diagnostic laboratories account for the second largest share.
Microtome Equipment Market by Region
Based on region, the global microtome equipment market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World. Healthcare infrastructure facilities, an increase in public and private sector investments in in-vitro diagnostics, the presence of numerous market players, and the adoption of technologically advanced products all contributed to North America's market dominance. Additionally, the rising incidence of cancer in North America is driving up the need for biopsies, which is driving up demand. The United States was the most important market in North America and is expected to generate the most revenue over the forecast period. This can be attributed to the growing laboratory automation and the rising demand for technologically advanced diagnostic equipment. Many local players fuel this microtome equipment market expansion in the United States. Demand for these devices is also anticipated to rise as product lines expand and new products enter the market. In Asia-Pacific, the microtome equipment market is anticipated to grow fastest. Significant expansion in this region is anticipated to be fueled by the burgeoning medical tourism sector, growing public awareness of the benefits of early diagnosis, and rising per capita income. The Middle East and Africa market is the smallest because of its little exposure to technological improvements and weak healthcare infrastructure.
Competitive Landscape
Some of the prominent players operating in the global microtome equipment market are:
Strategic Developments
In May 2018, Leica Biosystems, a Danaher division, expanded its histology supplies and equipment lineup by adding a new line of rotary microtomes. HistoCore BIOCUT, HistoCore MULTI CUT, and HistoCoreAUTOCUT clinical microtomes are among the devices included in this product launch.
The global microtome equipment market is expected to grow at a CAGR of 6.2% in the forecast period.
Leica Biosystems Nussloch GmbH, LLS ROWIAK LaserLabSolutions GmbH, Sakura Finetek Europe B.V., Boeckeler Instruments, and MICROS Austria Produktions-und Handelsges.m.b.H are a few key players in the global microtome equipment market.
The automated microtome devices have a greater demand in the global microtome equipment market.
Asia Pacific region is expected to witness the highest global microtome equipment market growth in the forecast period from 2022 to 2030.
The global microtome equipment market was US$ 164 million in 2021.
*Insights on financial performance are subject to the availability of information in the public domain
Using the fundamental research and knowledge services capabilities of GRG Health, Growth Plus Reports may now be tailored based on client needs.
GRG Health's unique GrowthMIX strategy and comprehensive research methodology enable us to provide unique and valuable insights to our clients while uncovering trends that would not be discovered using traditional techniques.